Vorinostat Withdrawn Phase 1 Trials for Advanced Cancers Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01608139Study of Curcumin, Vorinostat, and Sorafenib